Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Topical tacrolimus can effectively treat erosive pustular dermatosis and related hair loss.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Scalp cooling significantly reduces hair loss in chemotherapy patients.